Sponsors
Gold Level
Silver Level
Exhibitors
3Helix is dedicated to revolutionizing how fibrotic and inflammatory conditions are studied and treated. 3Helix accomplished this through our proprietary Collagen Hybridizing Peptides (CHPs); synthetic peptides which specifically bind to damaged collagen by recognizing its highly conserved 3D structure.
This has given researchers across many indications the ability to confidently determine disease activity and progress on the reversibility of fibrosis. Together, these observations help diagnose conditions, monitor treatment efficacy, and stratify patient populations based on the activity of their disease.
Please visit our booth to learn more about CHP technology and how its applications can help advance our understanding of collagen in dermatology
CELLnTEC is a pioneering provider of animal and human component-free, chemically defined precision media and technologies. Across the globe, CELLnTEC empowers scientists to conduct cell culture and tissue engineering, and to create sophisticated in vitro cell models in applications ranging from 2D/3D cell culture to organoids, lab-on-a-chip, or 3D bioprinting, across a range of tissue types, iPSC and ESC.
Our signature products are designed to successfully transverse the basic to translational research continuum and to support researchers establish clinical applications. One of the founding visions of CELLnTEC is to reduce animal testing in research. We are committed to providing non-animal, human biology-based research alternatives.
Highlights of CELLnTEC Product Range:
• One universal base formulation for a seamless transition across multiple applications
• Cell expansion in serum-free, xeno-free, or fully defined environment
• Higher Certified media: supports the establishment of clinical applications
• Precision media: accurate and highly reproducible 2D/3D in vitro modeling
• Functional media: modeling specific cell behaviour with in vivo-like assay responsiveness and sensitivity
• Primary cells: isolated, refined, and cryopreserved in CELLnTEC media to provide users a jumpstart experience
• Long-Term cells: stable and dependable modeling for research in the long term
• Supplementary reagents: cell culturing accessories
Our Prime Clients:
Basic and discovery research, pharmaceutical and regenerative medicine, wound care, cosmeceutical research, 3D bioprinting, or clean meat.
Dermus supports dermatologists by providing a portable and high-frequency ultrasound technology for evidence-based skin treatments.
SkinScanner
SkinScanner’s proprietary dermoscopy guidance allows the rapid and reproducible positioning of the device resulting in the simultaneous imaging of skin surface (12×12 mm) and depth (20-40 MHz, ≤10 mm). This patent-pending technology is ready to support all kinds of skin lesions, including the monitoring of skin cancer, skin inflammation, cosmetological and wound treatments.
SkinScanner is currently available for pre-clinical, clinical and cosmetic applications in certain regions. MDR CE Class IIa Certification is pending.
SkinAid
SkinAid is a web-based research package for evidence-based skin treatment analysis, where AI algorithms help in the immediate and objective quantification of skin changes. Smart image annotations, filters and settings are also available.
SkinAid comes with either a cloud or local storage provided at the discretion of the dermatologist. It enables patient management with anonymized data collection, and user-friendly exports and imports too.
Genemarkers is the leader in applying cutting-edge genomic technologies to the product development process. They have designed proprietary gene expression panels which screen for many functions such as anti-aging, acne, pigmentation, mitochondrial function & more. They can also challenge products with various stressors such as blue light or UV to determine any protective or reparative effects of products. Genemarkers is now offering next-generation sequencing, an innovative technology which detects novel and rare biomarkers, determines the effect of products on the skin/hair microbiome, and identifies epigenetic modification of aging, inflammation, and skin repair makers.
Innovaderm Research Inc. is a full-service CRO specialized in therapeutic dermatology.
Founded in 2000, it partners with biotech companies for the management of early to late phase clinical trials worldwide. Its mission is to drive research forward and offer new therapies for patients living with skin disease.
For more information, please visit : http://www.innovaderm.com
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company’s Specialty Brands reportable segment’s areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Since 1985, MatTek Life Sciences has been the leading innovator of lab-grown human tissue technology as reliable replacements for animal testing. MatTek’s physiologically advanced tissue models empower companies in the cosmetics, chemical, and pharmaceutical industries to achieve their goals of non-animal testing while lowering preclinical costs and providing human-relevant results. With locations in the US and Europe, today MatTek’s offerings include skin, eye, oral, respiratory, vaginal, and intestinal tissue models including disease modeling, validated, and custom testing services, multiple donor primary cells, culture media, and highly optical culture ware.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Ten Bio provides optimal human skin models for skin biology testing. By restoring and maintaining physiological skin tension using our unique culture platform, Ten Bio has succeeded in creating a truly functional and realistic testing platform for skin-based research. Our products and research services help generate exacting and clinically relevant data to more accurately predict product performance in vivo. Ten Bio can significantly lower R&D costs and accelerate product development.
Zen-Bio is a leading global provider of advanced cell-based solutions and services to the life sciences. The company, founded in 1995, was a pioneer in adipose derived stem cells and continues this legacy by providing the highest quality human cell systems, reagents, blood products and contract services to our partners.
Partners
